Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Seidenberg

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Preventive Medicine|December 26, 2021
U.S. public opinion toward policy restrictions to limit tobacco product placement and advertising at point-of-sale and on social mediaKelly D Blake, Anna Gaysynsky, Rachel Grana Mayne, et al.
Translational Behavioral Medicine|July 1, 2016
Tanning bed burns reported on Twitter: over 15,000 in 2013Andrew B Seidenberg, Sherry L Pagoto, Theodore A Vickey, et al.
Arthritis and Rheumatism|May 19, 2000
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study GroupG W Cannon, J R Caldwell, P Holt, et al.
American Journal of Preventive Medicine|May 21, 2013
Preventing skin cancer through reduction of indoor tanning: current evidenceMeg Watson, Dawn M Holman, Kathleen A Fox, et al.
International Journal of Environmental Research and Public Health|April 22, 2017
A National Study of Social Media, Television, Radio, and Internet Usage of Adults by Sexual Orientation and Smoking Status: Implications for Campaign DesignAndrew B Seidenberg, Catherine L Jo, Kurt M Ribisl, et al.
Drug and Alcohol Dependence|January 19, 2019
Adverse symptoms users attribute to e-cigarettes: Results from a national survey of US adultsJessica L King, Beth A Reboussin, Kimberly D Wiseman, et al.
Journal of the National Cancer Institute|January 31, 2024
Association of metformin use and cancer incidence: a systematic review and meta-analysisLauren O'Connor, Maeve Bailey-Whyte, Manami Bhattacharya, et al.
Tobacco Control|October 29, 2025
Responses to e-cigarette nicotine source descriptors: results from a randomised experimentAndrew B Seidenberg, Mona Azadi, Nathaniel A Silver, et al.
Tobacco Control|May 12, 2023
Synthetic nicotine descriptors: awareness and impact on perceptions of e-cigarettes among US youthSarah D Kowitt, Andrew B Seidenberg, Nisha C Gottfredson O'Shea, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Preventive Medicine|December 26, 2021
U.S. public opinion toward policy restrictions to limit tobacco product placement and advertising at point-of-sale and on social mediaKelly D Blake, Anna Gaysynsky, Rachel Grana Mayne, et al.
Translational Behavioral Medicine|July 1, 2016
Tanning bed burns reported on Twitter: over 15,000 in 2013Andrew B Seidenberg, Sherry L Pagoto, Theodore A Vickey, et al.
Arthritis and Rheumatism|May 19, 2000
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study GroupG W Cannon, J R Caldwell, P Holt, et al.
American Journal of Preventive Medicine|May 21, 2013
Preventing skin cancer through reduction of indoor tanning: current evidenceMeg Watson, Dawn M Holman, Kathleen A Fox, et al.
International Journal of Environmental Research and Public Health|April 22, 2017
A National Study of Social Media, Television, Radio, and Internet Usage of Adults by Sexual Orientation and Smoking Status: Implications for Campaign DesignAndrew B Seidenberg, Catherine L Jo, Kurt M Ribisl, et al.
Drug and Alcohol Dependence|January 19, 2019
Adverse symptoms users attribute to e-cigarettes: Results from a national survey of US adultsJessica L King, Beth A Reboussin, Kimberly D Wiseman, et al.
Journal of the National Cancer Institute|January 31, 2024
Association of metformin use and cancer incidence: a systematic review and meta-analysisLauren O'Connor, Maeve Bailey-Whyte, Manami Bhattacharya, et al.
Tobacco Control|October 29, 2025
Responses to e-cigarette nicotine source descriptors: results from a randomised experimentAndrew B Seidenberg, Mona Azadi, Nathaniel A Silver, et al.
Tobacco Control|May 12, 2023
Synthetic nicotine descriptors: awareness and impact on perceptions of e-cigarettes among US youthSarah D Kowitt, Andrew B Seidenberg, Nisha C Gottfredson O'Shea, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Pageof 8